EverSource Wealth Advisors’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$840K Buy
3,674
+475
+15% +$86.1K 0.03% 392
2026
Q1
$426K Buy
3,199
+2,604
+438% +$414K 0.01% 669
2025
Q4
$103K Sell
595
-2,905
-83% -$477K ﹤0.01% 1294
2025
Q3
$670K Buy
3,500
+2,344
+203% +$431K 0.03% 409
2025
Q2
$344K Buy
1,156
+759
+191% +$238K 0.02% 600
2025
Q1
$131K Buy
397
+201
+103% +$60.7K 0.01% 815
2024
Q4
$57K Buy
196
+88
+81% +$27.2K ﹤0.01% 1134
2024
Q3
$37.2K Sell
108
-13
-11% -$4.29K ﹤0.01% 1190
2024
Q2
$41.3K Sell
121
-37
-23% -$12.6K ﹤0.01% 1177
2024
Q1
$54.1K Sell
158
-4
-2% -$1.55K ﹤0.01% 955
2023
Q4
$58.5K Buy
162
+9
+6% +$3.17K 0.01% 837
2023
Q3
$50.2K Buy
153
+26
+20% +$8.18K 0.01% 805
2023
Q2
$38.3K Buy
127
+5
+4% +$1.44K ﹤0.01% 937
2023
Q1
$32.6K Buy
122
+118
+2,950% +$33.9K ﹤0.01% 936
2022
Q4
$1.32K Buy
4
+2
+100% +$679 ﹤0.01% 2027
2022
Q3
$1K Buy
+2
New +$644 ﹤0.01% 1849

Other funds holding MOH

EverSource Wealth Advisors's MOH Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Molina Healthcare (MOH) stake by 15% in Q2 2026, buying an estimated $86.1K and bringing the position to 3,674 shares worth $840K. The position accounts for 0.03% of the portfolio, ranked #392.

EverSource Wealth Advisors first reported a position in MOH in Q3 2022 and has held it in 16 quarters since. 599 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • EverSource Wealth Advisors held 3,674 shares of Molina Healthcare worth $840K as of Q2 2026.
  • EverSource Wealth Advisors bought 475 Molina Healthcare shares in Q2 2026, an estimated $86.1K.
  • Molina Healthcare made up 0.03% of EverSource Wealth Advisors's portfolio in Q2 2026, its #392 holding.
  • EverSource Wealth Advisors first reported a position in Molina Healthcare in Q3 2022 and has held it in 16 quarters since.
  • 599 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.